CWA Asset Management Group LLC Lowers Holdings in Cardinal Health, Inc. $CAH

CWA Asset Management Group LLC reduced its stake in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 23.3% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 85,946 shares of the company’s stock after selling 26,069 shares during the period. CWA Asset Management Group LLC’s holdings in Cardinal Health were worth $13,490,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Norges Bank purchased a new position in Cardinal Health during the second quarter valued at approximately $584,420,000. Zurich Insurance Group Ltd FI grew its stake in shares of Cardinal Health by 4,935.9% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after purchasing an additional 927,950 shares during the period. Acadian Asset Management LLC grew its stake in shares of Cardinal Health by 92.5% during the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock worth $282,063,000 after purchasing an additional 807,063 shares during the period. Prudential Financial Inc. increased its holdings in shares of Cardinal Health by 476.8% during the 2nd quarter. Prudential Financial Inc. now owns 883,348 shares of the company’s stock valued at $148,402,000 after purchasing an additional 730,209 shares in the last quarter. Finally, Voya Investment Management LLC lifted its stake in shares of Cardinal Health by 298.3% in the 3rd quarter. Voya Investment Management LLC now owns 821,723 shares of the company’s stock valued at $128,978,000 after purchasing an additional 615,398 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on CAH shares. Leerink Partners raised their price target on shares of Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research report on Monday, November 17th. Mizuho raised their target price on Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a research report on Monday, November 3rd. TD Cowen lifted their price target on Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, November 3rd. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Finally, Argus raised their price objective on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a report on Tuesday, November 4th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $209.00.

Get Our Latest Research Report on Cardinal Health

Cardinal Health Trading Up 0.0%

Shares of Cardinal Health stock opened at $205.60 on Monday. Cardinal Health, Inc. has a twelve month low of $118.44 and a twelve month high of $214.93. The firm has a market capitalization of $48.85 billion, a PE ratio of 31.01, a P/E/G ratio of 1.50 and a beta of 0.65. The firm’s 50-day moving average price is $200.99 and its 200 day moving average price is $171.79.

Cardinal Health (NYSE:CAHGet Free Report) last announced its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business’s revenue was up 22.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.88 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio is 30.77%.

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Read More

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.